{"document_type": "article", "byline": {"person": [{"firstname": "Steven", "organization": "", "lastname": "SOLOMON", "role": "reported", "rank": 1, "middlename": "Davidoff"}], "original": "By STEVEN DAVIDOFF SOLOMON"}, "news_desk": "Business", "slideshow_credits": null, "abstract": null, "multimedia": [], "headline": {"content_kicker": "Deal Professor", "main": "In Abbott\u2019s Bid to Halt Purchase of Alere, the MAC Makes a Comeback"}, "print_page": null, "keywords": [{"value": "Mergers, Acquisitions and Divestitures", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Suits and Litigation (Civil)", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Abbott Laboratories", "is_major": "N", "rank": "3", "name": "organizations"}, {"value": "St Jude Medical Inc", "is_major": "N", "rank": "4", "name": "organizations"}], "snippet": "Delaware courts have been tough to convince on material adverse change clauses, but this is one deal where the buyer might very well prevail....", "source": "The New York Times", "lead_paragraph": "Delaware courts have been tough to convince on material adverse change clauses, but this is one deal where the buyer might very well prevail.", "word_count": "1058", "pub_date": "2016-12-08T00:34:44+0000", "subsection_name": "DealBook", "blog": [], "type_of_material": "News", "section_name": "Business Day", "web_url": "http://www.nytimes.com/2016/12/07/business/dealbook/abbott-laboratories-alere-mac-clause.html", "_id": "5848aaa795d0e03926074bfa"}